Ethnic disparities in treatment rates for hypertension and dyslipidemia: an analysis by different treatment indications: the Healthy Life in an Urban Setting study

Journal of Hypertension
Wilco PeriniAnton E Kunst

Abstract

Studies have reported ethnic disparities in treatment rates for cardiovascular risk factors. These studies are generally based on treatment indications defined by individual cardiovascular risk factors (ICRF). However, according to most European guidelines, preventive treatment for these risk factors is recommended only among those with sufficient overall cardiovascular risk (OCR). To determine ethnic disparities in treatment rates for hypertension and dyslipidemia among those with an indication for treatment based on ICRF and OCR. Using data of the HELIUS study, we determined the occurrence of cardiovascular risk factors and treatment rates among 11 357 participants from six ethnic backgrounds living in Amsterdam. Via logistic regression analyses, we determined ethnic differences in blood pressure (BP)-lowering or lipid-lowering treatment rates among those needing treatment based on ICRF (BP >140 mmHg and LDL >2.5 mmol/l, respectively) and on OCR (estimated overall 10-year cardiovascular disease risk according to SCORE). Relative to the Dutch, ethnic minority men showed higher treatment rates for hypertension and dyslipidemia, regardless of whether OCR of ICRF recommendations for treatment were used. Ethnic minority women show...Continue Reading

References

Feb 10, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Scott M GrundyUNKNOWN American Heart Association
Jun 8, 2007·The New England Journal of Medicine·Earl S FordSimon Capewell
Apr 30, 2013·BMC Public Health·Karien StronksAeilko H Zwinderman
Oct 2, 2014·Stroke; a Journal of Cerebral Circulation·Charles AgyemangIlonca Vaartjes
Dec 3, 2014·Lancet·Johan SundströmBruce Neal
Feb 14, 2015·International Journal of Cardiology·Charles AgyemangKarien Stronks
Mar 16, 2016·Atherosclerosis·Ling PanUNKNOWN China National Survey of Chronic Kidney Disease Working Group
Mar 31, 2016·Internal and Emergency Medicine·Lizzy M BrewsterYackoob K Seedat
Feb 6, 2017·Journal of Diabetes Research·Marieke B SnijderIrene G M van Valkengoed

❮ Previous
Next ❯

Citations

Jul 28, 2019·European Journal of Preventive Cardiology·Wilco PeriniIrene Gm van Valkengoed

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

© 2022 Meta ULC. All rights reserved